Trial Profile
Randomized pilot study evaluating indisetron tablets for the prevention of acute-onset diarrhea, nausea and vomiting with IRIS or FOLFIRI for metastatic colorectal cancer patients: HGCSG 0704
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2014
Price :
$35
*
At a glance
- Drugs Indisetron (Primary) ; Granisetron
- Indications Chemotherapy-induced nausea and vomiting; Diarrhoea
- Focus Therapeutic Use
- 18 Jan 2014 Results presented at the 2014 Gastrointestinal Cancers Symposium.
- 13 Mar 2013 New trial record